Global Chemotherapy Induced Neutropenia Drug Sales Market Report 2020
SKU ID : QYR-16802392 | Publishing Date : 20-Nov-2020 | No. of pages : 147
Detailed TOC of Global Chemotherapy Induced Neutropenia Drug Sales Market Report 2020
1 Chemotherapy Induced Neutropenia Drug Market Overview1.1 Chemotherapy Induced Neutropenia Drug Product Scope
1.2 Chemotherapy Induced Neutropenia Drug Segment by Type
1.2.1 Global Chemotherapy Induced Neutropenia Drug Sales by Type (2020-2026)
1.2.2 F-627
1.2.3 BBT-018
1.2.4 Filgrastim
1.2.5 GW-003
1.2.6 NLA-101
1.2.7 Others
1.3 Chemotherapy Induced Neutropenia Drug Segment by Application
1.3.1 Global Chemotherapy Induced Neutropenia Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Chemotherapy Induced Neutropenia Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Chemotherapy Induced Neutropenia Drug Sales Growth Rate (2015-2026)
1.4.2 Global Chemotherapy Induced Neutropenia Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Chemotherapy Induced Neutropenia Drug Price Trends (2015-2026)
2 Chemotherapy Induced Neutropenia Drug Estimate and Forecast by Region
2.1 Global Chemotherapy Induced Neutropenia Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Chemotherapy Induced Neutropenia Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Chemotherapy Induced Neutropenia Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Region (2015-2020)
2.3 Global Chemotherapy Induced Neutropenia Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Chemotherapy Induced Neutropenia Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Chemotherapy Induced Neutropenia Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
2.4.2 Europe Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
2.4.3 China Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
2.4.4 Japan Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
2.4.6 India Chemotherapy Induced Neutropenia Drug Estimates and Projections (2015-2026)
3 Global Chemotherapy Induced Neutropenia Drug Competition Landscape by Players
3.1 Global Top Chemotherapy Induced Neutropenia Drug Players by Sales (2015-2020)
3.2 Global Top Chemotherapy Induced Neutropenia Drug Players by Revenue (2015-2020)
3.3 Global Chemotherapy Induced Neutropenia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Neutropenia Drug as of 2019)
3.4 Global Chemotherapy Induced Neutropenia Drug Average Price by Company (2015-2020)
3.5 Manufacturers Chemotherapy Induced Neutropenia Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Chemotherapy Induced Neutropenia Drug Players (Opinion Leaders)
4 Global Chemotherapy Induced Neutropenia Drug Market Size by Type
4.1 Global Chemotherapy Induced Neutropenia Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Chemotherapy Induced Neutropenia Drug Price by Type (2015-2020)
4.2 Global Chemotherapy Induced Neutropenia Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Chemotherapy Induced Neutropenia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Chemotherapy Induced Neutropenia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Chemotherapy Induced Neutropenia Drug Price Forecast by Type (2021-2026)
5 Global Chemotherapy Induced Neutropenia Drug Market Size by Application
5.1 Global Chemotherapy Induced Neutropenia Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Chemotherapy Induced Neutropenia Drug Price by Application (2015-2020)
5.2 Global Chemotherapy Induced Neutropenia Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Chemotherapy Induced Neutropenia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Chemotherapy Induced Neutropenia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Chemotherapy Induced Neutropenia Drug Price Forecast by Application (2021-2026)
6 United States Chemotherapy Induced Neutropenia Drug Market Facts & Figures
6.1 United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
6.2 United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
6.3 United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
7 Europe Chemotherapy Induced Neutropenia Drug Market Facts & Figures
7.1 Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
7.2 Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
7.3 Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
8 China Chemotherapy Induced Neutropenia Drug Market Facts & Figures
8.1 China Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
8.2 China Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
8.3 China Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
9 Japan Chemotherapy Induced Neutropenia Drug Market Facts & Figures
9.1 Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (3015-3030)
9.2 Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
9.3 Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Chemotherapy Induced Neutropenia Drug Market Facts & Figures
10.1 Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
11 India Chemotherapy Induced Neutropenia Drug Market Facts & Figures
11.1 India Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
11.2 India Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
11.3 India Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Chemotherapy Induced Neutropenia Drug Business
12.1 BeyondSpring Pharmaceuticals Inc
12.1.1 BeyondSpring Pharmaceuticals Inc Corporation Information
12.1.2 BeyondSpring Pharmaceuticals Inc Business Overview
12.1.3 BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.1.5 BeyondSpring Pharmaceuticals Inc Recent Development
12.2 Biocon Ltd
12.2.1 Biocon Ltd Corporation Information
12.2.2 Biocon Ltd Business Overview
12.2.3 Biocon Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biocon Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.2.5 Biocon Ltd Recent Development
12.3 Bolder Biotechnology Inc
12.3.1 Bolder Biotechnology Inc Corporation Information
12.3.2 Bolder Biotechnology Inc Business Overview
12.3.3 Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.3.5 Bolder Biotechnology Inc Recent Development
12.4 Cellerant Therapeutics Inc
12.4.1 Cellerant Therapeutics Inc Corporation Information
12.4.2 Cellerant Therapeutics Inc Business Overview
12.4.3 Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.4.5 Cellerant Therapeutics Inc Recent Development
12.5 Chong Kun Dang Pharmaceutical Corp
12.5.1 Chong Kun Dang Pharmaceutical Corp Corporation Information
12.5.2 Chong Kun Dang Pharmaceutical Corp Business Overview
12.5.3 Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Products Offered
12.5.5 Chong Kun Dang Pharmaceutical Corp Recent Development
12.6 Cinfa Biotech SL
12.6.1 Cinfa Biotech SL Corporation Information
12.6.2 Cinfa Biotech SL Business Overview
12.6.3 Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Products Offered
12.6.5 Cinfa Biotech SL Recent Development
12.7 Dr. Reddy's Laboratories Ltd
12.7.1 Dr. Reddy's Laboratories Ltd Corporation Information
12.7.2 Dr. Reddy's Laboratories Ltd Business Overview
12.7.3 Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.7.5 Dr. Reddy's Laboratories Ltd Recent Development
12.8 Gene Techno Science Co Ltd
12.8.1 Gene Techno Science Co Ltd Corporation Information
12.8.2 Gene Techno Science Co Ltd Business Overview
12.8.3 Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.8.5 Gene Techno Science Co Ltd Recent Development
12.9 Generon (Shanghai) Corp Ltd
12.9.1 Generon (Shanghai) Corp Ltd Corporation Information
12.9.2 Generon (Shanghai) Corp Ltd Business Overview
12.9.3 Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.9.5 Generon (Shanghai) Corp Ltd Recent Development
12.10 Genexine Inc
12.10.1 Genexine Inc Corporation Information
12.10.2 Genexine Inc Business Overview
12.10.3 Genexine Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Genexine Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.10.5 Genexine Inc Recent Development
12.11 GlycoMimetics Inc
12.11.1 GlycoMimetics Inc Corporation Information
12.11.2 GlycoMimetics Inc Business Overview
12.11.3 GlycoMimetics Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlycoMimetics Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.11.5 GlycoMimetics Inc Recent Development
12.12 Hanmi Pharmaceuticals Co Ltd
12.12.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
12.12.2 Hanmi Pharmaceuticals Co Ltd Business Overview
12.12.3 Hanmi Pharmaceuticals Co Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hanmi Pharmaceuticals Co Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.12.5 Hanmi Pharmaceuticals Co Ltd Recent Development
12.13 Intas Pharmaceuticals Ltd
12.13.1 Intas Pharmaceuticals Ltd Corporation Information
12.13.2 Intas Pharmaceuticals Ltd Business Overview
12.13.3 Intas Pharmaceuticals Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Intas Pharmaceuticals Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.13.5 Intas Pharmaceuticals Ltd Recent Development
12.14 Lupin Ltd
12.14.1 Lupin Ltd Corporation Information
12.14.2 Lupin Ltd Business Overview
12.14.3 Lupin Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lupin Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.14.5 Lupin Ltd Recent Development
12.15 Mycenax Biotech Inc
12.15.1 Mycenax Biotech Inc Corporation Information
12.15.2 Mycenax Biotech Inc Business Overview
12.15.3 Mycenax Biotech Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Mycenax Biotech Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.15.5 Mycenax Biotech Inc Recent Development
12.16 Myelo Therapeutics GmbH
12.16.1 Myelo Therapeutics GmbH Corporation Information
12.16.2 Myelo Therapeutics GmbH Business Overview
12.16.3 Myelo Therapeutics GmbH Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Myelo Therapeutics GmbH Chemotherapy Induced Neutropenia Drug Products Offered
12.16.5 Myelo Therapeutics GmbH Recent Development
12.17 Nohla Therapeutics Inc
12.17.1 Nohla Therapeutics Inc Corporation Information
12.17.2 Nohla Therapeutics Inc Business Overview
12.17.3 Nohla Therapeutics Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Nohla Therapeutics Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.17.5 Nohla Therapeutics Inc Recent Development
12.18 Octapharma AG
12.18.1 Octapharma AG Corporation Information
12.18.2 Octapharma AG Business Overview
12.18.3 Octapharma AG Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Octapharma AG Chemotherapy Induced Neutropenia Drug Products Offered
12.18.5 Octapharma AG Recent Development
12.19 Pangen Biotech Inc.
12.19.1 Pangen Biotech Inc. Corporation Information
12.19.2 Pangen Biotech Inc. Business Overview
12.19.3 Pangen Biotech Inc. Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Pangen Biotech Inc. Chemotherapy Induced Neutropenia Drug Products Offered
12.19.5 Pangen Biotech Inc. Recent Development
12.20 Pfenex Inc
12.20.1 Pfenex Inc Corporation Information
12.20.2 Pfenex Inc Business Overview
12.20.3 Pfenex Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Pfenex Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.20.5 Pfenex Inc Recent Development
12.21 Pfizer Inc
12.21.1 Pfizer Inc Corporation Information
12.21.2 Pfizer Inc Business Overview
12.21.3 Pfizer Inc Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Pfizer Inc Chemotherapy Induced Neutropenia Drug Products Offered
12.21.5 Pfizer Inc Recent Development
12.22 Reliance Life Sciences Pvt Ltd
12.22.1 Reliance Life Sciences Pvt Ltd Corporation Information
12.22.2 Reliance Life Sciences Pvt Ltd Business Overview
12.22.3 Reliance Life Sciences Pvt Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Reliance Life Sciences Pvt Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.22.5 Reliance Life Sciences Pvt Ltd Recent Development
12.23 Richter Gedeon Nyrt
12.23.1 Richter Gedeon Nyrt Corporation Information
12.23.2 Richter Gedeon Nyrt Business Overview
12.23.3 Richter Gedeon Nyrt Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Richter Gedeon Nyrt Chemotherapy Induced Neutropenia Drug Products Offered
12.23.5 Richter Gedeon Nyrt Recent Development
12.24 Sandoz International GmbH
12.24.1 Sandoz International GmbH Corporation Information
12.24.2 Sandoz International GmbH Business Overview
12.24.3 Sandoz International GmbH Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Sandoz International GmbH Chemotherapy Induced Neutropenia Drug Products Offered
12.24.5 Sandoz International GmbH Recent Development
12.25 USV Pvt Ltd
12.25.1 USV Pvt Ltd Corporation Information
12.25.2 USV Pvt Ltd Business Overview
12.25.3 USV Pvt Ltd Chemotherapy Induced Neutropenia Drug Sales, Revenue and Gross Margin (2015-2020)
12.25.4 USV Pvt Ltd Chemotherapy Induced Neutropenia Drug Products Offered
12.25.5 USV Pvt Ltd Recent Development
13 Chemotherapy Induced Neutropenia Drug Manufacturing Cost Analysis
13.1 Chemotherapy Induced Neutropenia Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Chemotherapy Induced Neutropenia Drug
13.4 Chemotherapy Induced Neutropenia Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Chemotherapy Induced Neutropenia Drug Distributors List
14.3 Chemotherapy Induced Neutropenia Drug Customers
15 Market Dynamics
15.1 Chemotherapy Induced Neutropenia Drug Market Trends
15.2 Chemotherapy Induced Neutropenia Drug Opportunities and Drivers
15.3 Chemotherapy Induced Neutropenia Drug Market Challenges
15.4 Chemotherapy Induced Neutropenia Drug Market Restraints
15.5 Porter's Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Figures, Tables and Charts Available in Global Chemotherapy Induced Neutropenia Drug Sales Market Report 2020
List of TablesTable 1. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Chemotherapy Induced Neutropenia Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Chemotherapy Induced Neutropenia Drug Sales Market Share by Region (2015-2020)
Table 6. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Region (2015-2020)
Table 8. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Chemotherapy Induced Neutropenia Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Chemotherapy Induced Neutropenia Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Chemotherapy Induced Neutropenia Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Chemotherapy Induced Neutropenia Drug Sales Share by Company (2015-2020)
Table 14. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Company (2015-2020)
Table 16. Global Chemotherapy Induced Neutropenia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Neutropenia Drug as of 2019)
Table 17. Global Chemotherapy Induced Neutropenia Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Chemotherapy Induced Neutropenia Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Chemotherapy Induced Neutropenia Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Chemotherapy Induced Neutropenia Drug Players
Table 22. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Chemotherapy Induced Neutropenia Drug Sales Share by Type (2015-2020)
Table 24. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Chemotherapy Induced Neutropenia Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Chemotherapy Induced Neutropenia Drug Sales Share by Type (2021-2026)
Table 27. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Type (2021-2026)
Table 29. Global Chemotherapy Induced Neutropenia Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Chemotherapy Induced Neutropenia Drug Sales Share by Application (2015-2020)
Table 32. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Chemotherapy Induced Neutropenia Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Chemotherapy Induced Neutropenia Drug Sales Share by Application (2021-2026)
Table 36. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Application (2021-2026)
Table 38. Global Chemotherapy Induced Neutropenia Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 41. United States Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 43. United States Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 51. China Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 53. China Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 55. China Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
Table 69. India Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Company (2015-2020)
Table 71. India Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Type (2015-2020)
Table 73. India Chemotherapy Induced Neutropenia Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Application (2015-2020)
Table 75. BeyondSpring Pharmaceuticals Inc Corporation Information
Table 76. BeyondSpring Pharmaceuticals Inc Description and Business Overview
Table 77. BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Product
Table 79. BeyondSpring Pharmaceuticals Inc Recent Development
Table 80. Biocon Ltd Corporation Information
Table 81. Biocon Ltd Description and Business Overview
Table 82. Biocon Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Biocon Ltd Chemotherapy Induced Neutropenia Drug Product
Table 84. Biocon Ltd Recent Development
Table 85. Bolder Biotechnology Inc Corporation Information
Table 86. Bolder Biotechnology Inc Description and Business Overview
Table 87. Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Product
Table 89. Bolder Biotechnology Inc Recent Development
Table 90. Cellerant Therapeutics Inc Corporation Information
Table 91. Cellerant Therapeutics Inc Description and Business Overview
Table 92. Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Product
Table 94. Cellerant Therapeutics Inc Recent Development
Table 95. Chong Kun Dang Pharmaceutical Corp Corporation Information
Table 96. Chong Kun Dang Pharmaceutical Corp Description and Business Overview
Table 97. Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Product
Table 99. Chong Kun Dang Pharmaceutical Corp Recent Development
Table 100. Cinfa Biotech SL Corporation Information
Table 101. Cinfa Biotech SL Description and Business Overview
Table 102. Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Product
Table 104. Cinfa Biotech SL Recent Development
Table 105. Dr. Reddy's Laboratories Ltd Corporation Information
Table 106. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 107. Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Product
Table 109. Dr. Reddy's Laboratories Ltd Recent Development
Table 110. Gene Techno Science Co Ltd Corporation Information
Table 111. Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Gene Techno Science Co Ltd Description and Business Overview
Table 113. Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Product
Table 114. Gene Techno Science Co Ltd Recent Development
Table 115. Generon (Shanghai) Corp Ltd Corporation Information
Table 116. Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Generon (Shanghai) Corp Ltd Description and Business Overview
Table 118. Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Product
Table 119. Generon (Shanghai) Corp Ltd Recent Development
Table 120. Genexine Inc Corporation Information
Table 121. Genexine Inc Description and Business Overview
Table 122. Genexine Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Genexine Inc Chemotherapy Induced Neutropenia Drug Product
Table 124. Genexine Inc Recent Development
Table 125. GlycoMimetics Inc Corporation Information
Table 126. GlycoMimetics Inc Description and Business Overview
Table 127. GlycoMimetics Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. GlycoMimetics Inc Chemotherapy Induced Neutropenia Drug Product
Table 129. GlycoMimetics Inc Recent Development
Table 130. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 131. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
Table 132. Hanmi Pharmaceuticals Co Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Hanmi Pharmaceuticals Co Ltd Chemotherapy Induced Neutropenia Drug Product
Table 134. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 135. Intas Pharmaceuticals Ltd Corporation Information
Table 136. Intas Pharmaceuticals Ltd Description and Business Overview
Table 137. Intas Pharmaceuticals Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Intas Pharmaceuticals Ltd Chemotherapy Induced Neutropenia Drug Product
Table 139. Intas Pharmaceuticals Ltd Recent Development
Table 140. Lupin Ltd Corporation Information
Table 141. Lupin Ltd Description and Business Overview
Table 142. Lupin Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Lupin Ltd Chemotherapy Induced Neutropenia Drug Product
Table 144. Lupin Ltd Recent Development
Table 145. Mycenax Biotech Inc Corporation Information
Table 146. Mycenax Biotech Inc Description and Business Overview
Table 147. Mycenax Biotech Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Mycenax Biotech Inc Chemotherapy Induced Neutropenia Drug Product
Table 149. Mycenax Biotech Inc Recent Development
Table 150. Myelo Therapeutics GmbH Corporation Information
Table 151. Myelo Therapeutics GmbH Description and Business Overview
Table 152. Myelo Therapeutics GmbH Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Myelo Therapeutics GmbH Chemotherapy Induced Neutropenia Drug Product
Table 154. Myelo Therapeutics GmbH Recent Development
Table 155. Nohla Therapeutics Inc Corporation Information
Table 156. Nohla Therapeutics Inc Description and Business Overview
Table 157. Nohla Therapeutics Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Nohla Therapeutics Inc Chemotherapy Induced Neutropenia Drug Product
Table 159. Nohla Therapeutics Inc Recent Development
Table 160. Octapharma AG Corporation Information
Table 161. Octapharma AG Description and Business Overview
Table 162. Octapharma AG Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Octapharma AG Chemotherapy Induced Neutropenia Drug Product
Table 164. Octapharma AG Recent Development
Table 165. Pangen Biotech Inc. Corporation Information
Table 166. Pangen Biotech Inc. Description and Business Overview
Table 167. Pangen Biotech Inc. Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 168. Pangen Biotech Inc. Chemotherapy Induced Neutropenia Drug Product
Table 169. Pangen Biotech Inc. Recent Development
Table 170. Pfenex Inc Corporation Information
Table 171. Pfenex Inc Description and Business Overview
Table 172. Pfenex Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 173. Pfenex Inc Chemotherapy Induced Neutropenia Drug Product
Table 174. Pfenex Inc Recent Development
Table 175. Pfizer Inc Corporation Information
Table 176. Pfizer Inc Description and Business Overview
Table 177. Pfizer Inc Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 178. Pfizer Inc Chemotherapy Induced Neutropenia Drug Product
Table 179. Pfizer Inc Recent Development
Table 180. Reliance Life Sciences Pvt Ltd Corporation Information
Table 181. Reliance Life Sciences Pvt Ltd Description and Business Overview
Table 182. Reliance Life Sciences Pvt Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 183. Reliance Life Sciences Pvt Ltd Chemotherapy Induced Neutropenia Drug Product
Table 184. Reliance Life Sciences Pvt Ltd Recent Development
Table 185. Richter Gedeon Nyrt Corporation Information
Table 186. Richter Gedeon Nyrt Description and Business Overview
Table 187. Richter Gedeon Nyrt Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 188. Richter Gedeon Nyrt Chemotherapy Induced Neutropenia Drug Product
Table 189. Richter Gedeon Nyrt Recent Development
Table 190. Sandoz International GmbH Corporation Information
Table 191. Sandoz International GmbH Description and Business Overview
Table 192. Sandoz International GmbH Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 193. Sandoz International GmbH Chemotherapy Induced Neutropenia Drug Product
Table 194. Sandoz International GmbH Recent Development
Table 195. USV Pvt Ltd Corporation Information
Table 196. USV Pvt Ltd Description and Business Overview
Table 197. USV Pvt Ltd Chemotherapy Induced Neutropenia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 198. USV Pvt Ltd Chemotherapy Induced Neutropenia Drug Product
Table 199. USV Pvt Ltd Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Chemotherapy Induced Neutropenia Drug Distributors List
Table 203. Chemotherapy Induced Neutropenia Drug Customers List
Table 204. Chemotherapy Induced Neutropenia Drug Market Key Trends
Table 205. Chemotherapy Induced Neutropenia Drug Key Opportunities and Drivers
Table 206. Chemotherapy Induced Neutropenia Drug Market Challenges
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy Induced Neutropenia Drug Product Picture
Figure 2. Global Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Chemotherapy Induced Neutropenia Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Chemotherapy Induced Neutropenia Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Chemotherapy Induced Neutropenia Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Chemotherapy Induced Neutropenia Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Chemotherapy Induced Neutropenia Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Chemotherapy Induced Neutropenia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Chemotherapy Induced Neutropenia Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Chemotherapy Induced Neutropenia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Chemotherapy Induced Neutropenia Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Chemotherapy Induced Neutropenia Drug Players Market Share by Revenue in Chemotherapy Induced Neutropenia Drug 2015 & 2019
Figure 27. Chemotherapy Induced Neutropenia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Type (2015-2020)
Figure 29. Global Chemotherapy Induced Neutropenia Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Chemotherapy Induced Neutropenia Drug Revenue Share by Application (2015-2020)
Figure 31. Global Chemotherapy Induced Neutropenia Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 33. United States Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 34. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Company in 2019
Figure 35. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 36. Europe Chemotherapy Induced Neutropenia Drug Sales Market Share by Application in 2019
Figure 37. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Company in 2019
Figure 38. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 39. China Chemotherapy Induced Neutropenia Drug Sales Market Share by Application in 2019
Figure 40. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Company in 2019
Figure 41. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 42. Japan Chemotherapy Induced Neutropenia Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Chemotherapy Induced Neutropenia Drug Sales Market Share by Application in 2019
Figure 46. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Company in 2019
Figure 47. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Type in 2019
Figure 48. India Chemotherapy Induced Neutropenia Drug Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Chemotherapy Induced Neutropenia Drug
Figure 51. Manufacturing Process Analysis of Chemotherapy Induced Neutropenia Drug
Figure 52. Chemotherapy Induced Neutropenia Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Keyplayers in Global Chemotherapy Induced Neutropenia Drug Sales Market Report 2020
BeyondSpring Pharmaceuticals IncBiocon Ltd
Bolder Biotechnology Inc
Cellerant Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Cinfa Biotech SL
Dr. Reddy's Laboratories Ltd
Gene Techno Science Co Ltd
Generon (Shanghai) Corp Ltd
Genexine Inc
GlycoMimetics Inc
Hanmi Pharmaceuticals Co Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Mycenax Biotech Inc
Myelo Therapeutics GmbH
Nohla Therapeutics Inc
Octapharma AG
Pangen Biotech Inc.
Pfenex Inc
Pfizer Inc
Reliance Life Sciences Pvt Ltd
Richter Gedeon Nyrt
Sandoz International GmbH
USV Pvt Ltd